PharmaIN Corporation
Records under this name other than the patents PharmaIN Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 15 patents it holds.
Showing 1 to 9 of 9 · Back to PharmaIN Corporation
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,790,140 | Compositions for delivery of therapeutics and other materials, and methods of making and using the same Term ended Term ended Jan 26, 2026 · From the USPTO record | Term ended | Term ended Jan 26, 2026 | From the USPTO record |
| US 10,010,613 | Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same Surrendered on reissue Surrendered on reissue Oct 7, 2025 · From the USPTO record | Surrendered on reissue | Surrendered on reissue Oct 7, 2025 | From the USPTO record |
| US 8,257,682 | Compositions for delivery of therapeutics and other materials Term ended Term ended Mar 22, 2024 · From the USPTO record | Term ended | Term ended Mar 22, 2024 | From the USPTO record |
| US 8,277,776 | Compositions for delivery of therapeutics and other materials Term ended Term ended Jan 12, 2024 · From the USPTO record | Term ended | Term ended Jan 12, 2024 | From the USPTO record |
| US 8,231,859 | Compositions for delivery of therapeutics and other materials Term ended Term ended Nov 24, 2023 · From the USPTO record | Term ended | Term ended Nov 24, 2023 | From the USPTO record |
| US 7,138,105 | Compositions for delivery of therapeutics and other materials, and methods of making and using the same Term ended Term ended Nov 20, 2023 · From the USPTO record | Term ended | Term ended Nov 20, 2023 | From the USPTO record |
| US 7,589,169 | Compositions for treatment with glucagon-like peptide, and methods of making and using the same Term ended Ended no later than Feb 27, 2023 · From the USPTO record | Term ended | Ended no later than Feb 27, 2023 | From the USPTO record |
| US 7,635,463 | Compositions for delivery of therapeutics and other materials Term ended Ended no later than Feb 27, 2023 · From the USPTO record | Term ended | Ended no later than Feb 27, 2023 | From the USPTO record |
| US 5,118,799 | Process for converting crystalline erythromycin ethylsuccinate into stable amorphous erythromycin ethylsuccinate Term ended Term ended no later than Jun 2, 2012 · Low confidence | Term ended | Term ended no later than Jun 2, 2012 | Low confidence |